Acute promyelocytic leukemia Screening

Acute promyelocytic leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acute promyelocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Studies
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary PreventionSurgery
Secondary PreventionSurgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute promyelocytic leukemia Screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute promyelocytic leukemia Screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute promyelocytic leukemia Screening
CDC on Acute promyelocytic leukemia Screening
Acute promyelocytic leukemia Screening in the news
Blogs on Acute promyelocytic leukemia Screening
Directions to Hospitals Treating Acute promyelocytic leukemia
Risk calculators and risk factors for Acute promyelocytic leukemia Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

• [Condition 1]
• [Condition 2]
• [Condition 3]